Literature DB >> 3708223

Modulation of [3H]-dopamine released by different frequencies of stimulation from rabbit retina.

M L Dubocovich, J G Hensler.   

Abstract

Rabbit retinal pieces were incubated with [3H]-dopamine and superfused with Krebs solution. Calcium-dependent tritium release was elicited twice within each experiment by electrical field stimulation (360 pulses, 2 ms, 20 mA) at frequencies of 1 Hz, 3 Hz, and 6 Hz. The evoked release of [3H]-dopamine for the first period of stimulation (S1) was 2.09 +/- 0.23% (n = 5) at 1 Hz and was of similar magnitude at all other frequencies of stimulation employed. The D2-dopamine receptor agonist, LY 171555 (quinpirole HCl; 0.01-1 microM) added to the superfusion medium before the second period of stimulation, inhibited the calcium-dependent release of [3H]-dopamine in a concentration-dependent manner, and was more potent the lower the stimulation frequency. The isomer of quinpirole, LY 181990 (0.01-1 microM) did not inhibit the stimulation-evoked overflow of tritium, regardless of concentration or stimulation frequency. The stereoisomers of the D2-dopamine receptor antagonist sulpiride (0.01-3 microM) increased the calcium-dependent release of [3H]-dopamine in a concentration-dependent manner, being more potent the higher the frequency of stimulation. S-sulpiride was more potent than R-sulpiride at all stimulation frequencies. The inhibitory effect of quinpirole was stereoselectively antagonized by sulpiride, but not by LY 181990. The alpha-adrenoceptor antagonist phentolamine (1 microM) did not modify the quinpirole-induced inhibition of [3H]-dopamine release. When the synaptic concentration of dopamine was increased by the presence of the dopamine uptake inhibitor nomifensine (3 microM), the potency of the agonist quinpirole in inhibiting the release of [3H]-dopamine elicited by field stimulation at 1 Hz (180 pulses) was decreased. In contrast, the potency of S-sulpiride in enhancing the evoked release of [3H]-dopamine was increased when nomifensine was present in the superfusion medium. Picomolar concentrations of the hormone melatonin (0.1-10 nM) inhibited the calcium-dependent release of [3H]-dopamine from rabbit retina with the same potency regardless of the frequency of stimulation applied (1 Hz, 3 Hz or 6 Hz). The potency of D2-dopamine receptor agonists and antagonists in modifying [3H]-dopamine release from rabbit retina appears to depend on the synaptic concentration of dopamine which is altered by the frequency of stimulation, and by the dopamine uptake inhibitor nomifensine.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708223      PMCID: PMC1917121          DOI: 10.1111/j.1476-5381.1986.tb09470.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Enkephalins modulate [3H]dopamine release from rabbit retina in vitro.

Authors:  M L Dubocovich; N Weiner
Journal:  J Pharmacol Exp Ther       Date:  1983-03       Impact factor: 4.030

3.  Modulation of the stimulation-evoked release of [3H]dopamine in the rabbit retina.

Authors:  M L Dubocovich; N Weiner
Journal:  J Pharmacol Exp Ther       Date:  1981-12       Impact factor: 4.030

4.  Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor.

Authors:  K Tsuruta; E A Frey; C W Grewe; T E Cote; R L Eskay; J W Kebabian
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

5.  Inhibition of [3H]dopamine accumulation in rat striatal synaptosomes by psychotropic drugs.

Authors:  J Hyttel
Journal:  Biochem Pharmacol       Date:  1978-04-01       Impact factor: 5.858

6.  alpha-Adrenoceptor-mediated inhibition of noradrenaline release in rabbit brain cortex slices. Receptor properties and role of the biophase concentration of noradrenaline.

Authors:  D Reichenbacher; W Reimann; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

7.  Pathways of dopamine metabolism in the rabbit caudate nucleus in vitro.

Authors:  A Zumstein; W Karduck; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

8.  Antidopaminergic properties of yohimbine.

Authors:  B Scatton; B Zivkovic; J Dedek
Journal:  J Pharmacol Exp Ther       Date:  1980-11       Impact factor: 4.030

9.  Stereoselectivity of presynaptic autoreceptors modulating dopamine release.

Authors:  S Arbilla; S Z Langer
Journal:  Eur J Pharmacol       Date:  1981-12-17       Impact factor: 4.432

10.  Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.

Authors:  J Lehmann; M Briley; S Z Langer
Journal:  Eur J Pharmacol       Date:  1983-03-18       Impact factor: 4.432

View more
  3 in total

1.  Transmitter release patterns of noradrenergic, dopaminergic and cholinergic axons in rabbit brain slices during short pulse trains, and the operation of presynaptic autoreceptors.

Authors:  A Mayer; N Limberger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

2.  Autoinhibition of histamine release by H3 receptors in rat brain cortex depends on stimulation frequency.

Authors:  A van der Vliet; A Bast; H Timmerman
Journal:  Agents Actions       Date:  1990-04

3.  Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta.

Authors:  M G Lacey; N B Mercuri; R A North
Journal:  J Physiol       Date:  1987-11       Impact factor: 5.182

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.